Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis
Harter P, Loibl S, Meier W, Huober J, Fink D, Schroeder W, Muenstedt K, Schmalfeldt B, Emons G, Burges A, Hasenburg A, Hahmann M, Lueck H, Poelcher M, Wimberger P, Ortmann O, Canzler U, Richter B, Wagner U, du Bois A. Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of surgical oncology 2009; 16:1324-30.
May 1, 2009Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis
May 1, 2009Annals of surgical oncology 2009; 16:1324-30
Harter P, Loibl S, Meier W, Huober Jens, Fink D, Schroeder W, Muenstedt K, Schmalfeldt B, Emons G, Burges A, Hasenburg A, Hahmann M, Lueck H J, Poelcher M, Wimberger P, Ortmann O, Canzler U, Richter B, Wagner U, du Bois A
Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer
Winder T, de Vries A, Wenzl E, Drexel H, Knauer M, Hartmann B, Dirschmid K, Rhomberg S, Mündlein A, Lang A. Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer. Oncol Rep 2009; 21:1283-7.
May 1, 2009Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer
May 1, 2009Oncol Rep 2009; 21:1283-7
Winder Thomas, de Vries Alexander, Wenzl Etienne, Drexel Heinz, Knauer Michael, Hartmann Bernd L, Dirschmid Klaus, Rhomberg Simone, Mündlein Axel, Lang Alois
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer
Smit E, van Zandwijk N, Vincent A, Schellens J, Jörger M, Dingemans A, Eppinga P, Smit H, Biesma B, Burgers S, Groen H. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:2038-45.
Apr 20, 2009Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer
Apr 20, 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:2038-45
Smit Egbert F, van Zandwijk Nico, Vincent Andrew, Schellens Jan H, Jörger Markus, Dingemans Anne-Marie C, Eppinga Pier, Smit Hans J M, Biesma Bonne, Burgers Sjaak A, Groen Harry J M
Erlösung - leeres Wort oder Mysterium?
Renz M. Erlösung - leeres Wort oder Mysterium? - Wie kann Jesus Christus, der vor 2000 Jahren gestorben ist, heutige Menschen aus ihrer Schuld befreien?. St. Galler Tagblatt 2009; 11. Apr.:10.
Apr 11, 2009Erlösung - leeres Wort oder Mysterium?
Apr 11, 2009St. Galler Tagblatt 2009; 11. Apr.:10
Renz Monika
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Chan S, Frimodt-Moller B, Vaury A, Carrasco E, Jones A, Harrison M, Antón A, Mayordomo J, Kreienberg R, du Bois A, Llombart A, Lluch A, Schneeweiss A, Tubiana-Hulin M, Delozier T, Huober J, Romieu G, Fumoleau P. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60.
Apr 10, 2009Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Apr 10, 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60
Chan Stephen, Frimodt-Moller Bente, Vaury A Thareau, Carrasco Eva, Jones Alison, Harrison Mark, Antón Antonio, Mayordomo Jose Ignacio, Kreienberg Rolf, du Bois Andreas, Llombart Antonio, Lluch Ana, Schneeweiss Andreas, Tubiana-Hulin Michele, Delozier Thierry, Huober Jens, Romieu Gilles, Fumoleau Pierre
Schnelle Heilsantwort am Wochenendseminar
Renz M. Schnelle Heilsantwort am Wochenendseminar. Wendekreis 2009; April:5-6.
Apr 1, 2009Schnelle Heilsantwort am Wochenendseminar
Apr 1, 2009Wendekreis 2009; April:5-6
Renz Monika
Interpreting study designs in surgical research: a practical guide for surgeons and surgical residents
Ridgway P, Gueller U. Interpreting study designs in surgical research: a practical guide for surgeons and surgical residents. J Am Coll Surg 2009; 208:635-45.
Apr 1, 2009Interpreting study designs in surgical research: a practical guide for surgeons and surgical residents
Apr 1, 2009J Am Coll Surg 2009; 208:635-45
Ridgway Paul F, Gueller Ulrich
Vaccines against nicotine
Cerny E, Cerny T. Vaccines against nicotine. Human vaccines 2009; 5:200-5.
Apr 1, 2009Vaccines against nicotine
Apr 1, 2009Human vaccines 2009; 5:200-5
Cerny Erich H, Cerny Thomas
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer
Schittenhelm M, Bokemeyer C, Wong K, Corless C, Kanz L, Störkel S, Kurek R, Honecker F, Morich J, Harlow A, Oechsle K, Kollmannsberger C, Heinrich M. Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer. Mol Cancer Ther 2009; 8:481-9.
Mar 10, 2009Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer
Mar 10, 2009Mol Cancer Ther 2009; 8:481-9
Schittenhelm Marcus, Bokemeyer Carsten, Wong Kwok-Kin, Corless Christopher L, Kanz Lothar, Störkel Stephan, Kurek Raffael, Honecker Friedemann, Morich Jason, Harlow Amy, Oechsle Karin, Kollmannsberger Christian, Heinrich Michael C
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
Ribi K, Pestalozzi B, Lombriser N, Borner M, von Moos R, Moosmann P, Hess V, Roth A, Honegger H, Schuller J, Köberle D, Ruhstaller T. Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009; 17:1109-1116.
Feb 7, 2009Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
Feb 7, 2009Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009; 17:1109-1116
Ribi Karin, Pestalozzi Bernhard, Lombriser Norbert, Borner Markus, von Moos Roger, Moosmann Peter, Hess Viviane, Roth Arnaud, Honegger Hanspeter, Schuller Jan C, Köberle Dieter, Ruhstaller Thomas
Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.
Khanna N, Steffen I, Studt J, Schreiber A, Lehmann T, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch H. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009; 11:100-5.
Jan 20, 2009Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.
Jan 20, 2009Transpl Infect Dis 2009; 11:100-5
Khanna N, Steffen Imke, Studt J-D, Schreiber A, Lehmann Thomas, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch H H
Aplastic anemia and concomitant autoimmune diseases
Stalder M, Tichelli A, Meyer-Monard S, Buser A, Arber C, Stern M, Rischewski J, Passweg J, Silzle T, Heim D, Halter J, Rovó A, Gratwohl A. Aplastic anemia and concomitant autoimmune diseases. Ann Hematol 2009; 88:659-65.
Jan 13, 2009Aplastic anemia and concomitant autoimmune diseases
Jan 13, 2009Ann Hematol 2009; 88:659-65
Stalder Magnus P, Tichelli André, Meyer-Monard Sandrine, Buser Andreas, Arber Caroline, Stern Martin, Rischewski Johannes, Passweg Jakob, Silzle Tobias, Heim Dominik, Halter Jörg, Rovó Alicia, Gratwohl Alois
Receptor-mediated targeting of cathepsins in professional antigen presenting cells
Hillaert U, Driessen C, van der Marel G, Ossendorp F, Van Calenbergh S, Kuiper J, Habets K, Saragliadis A, Saragliadis A, Florea B, Verdoes M, Overkleeft H. Receptor-mediated targeting of cathepsins in professional antigen presenting cells. Angewandte Chemie (International ed. in English) 2009; 48:1629-32.
Jan 1, 2009Receptor-mediated targeting of cathepsins in professional antigen presenting cells
Jan 1, 2009Angewandte Chemie (International ed. in English) 2009; 48:1629-32
Hillaert Ulrik, Driessen Christoph, van der Marel Gijsbert A, Ossendorp Ferry, Van Calenbergh Serge, Kuiper Johan, Habets Kim L L, Saragliadis Anastasios, Saragliadis Athanasios, Florea Bogdan I, Verdoes Martijn, Overkleeft Hermen S
Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom
Baumann M, Weder P, Köberle D. Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom - Bewertung der aktuellen Studeienresultate und Konsequenzen. Schweizer Zeitschrift für Onkologie 2009:14-19.
Jan 1, 2009Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom
Jan 1, 2009Schweizer Zeitschrift für Onkologie 2009:14-19
Baumann Michael, Weder Patrik, Köberle Dieter
Concordant colon tumors in monozygotic twins previously treated for prostate cancer
Templeton A, Marra G, Valtorta E, Heinimann K, Müller H, Köberle D, Gillessen Sommer S. Concordant colon tumors in monozygotic twins previously treated for prostate cancer. Familial cancer 2009; 8:167-71.
Jan 1, 2009Concordant colon tumors in monozygotic twins previously treated for prostate cancer
Jan 1, 2009Familial cancer 2009; 8:167-71
Templeton Arnoud, Marra Giancarlo, Valtorta Emanuele, Heinimann Karl, Müller Hansjakob, Köberle Dieter, Gillessen Sommer Silke
Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study
Ruhstaller T, Böhme C, Hess D, Hoefliger M, Mueller U, Köberle D, Spaeti B, Glaus A, Ribi K, Rufibach K, von Moos R, Thürlimann B. Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study. Oncology 2009; 76:142-8.
Jan 1, 2009Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study
Jan 1, 2009Oncology 2009; 76:142-8
Ruhstaller Thomas, Böhme Christel, Hess Dagmar, Hoefliger Markus, Mueller Urs, Köberle Dieter, Spaeti Bruno, Glaus Agnes, Ribi Karin, Rufibach Kaspar, von Moos Roger, Thürlimann Beat
Gewichts- und Appetitverlust bei Krebspatienten
Blum D, Omlin A, Strasser F. Gewichts- und Appetitverlust bei Krebspatienten. The Medical Journal 2009 2009; 3:27-29.
Jan 1, 2009Gewichts- und Appetitverlust bei Krebspatienten
Jan 1, 2009The Medical Journal 2009 2009; 3:27-29
Blum David, Omlin Aurelius, Strasser Florian
Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report
Spirig C, Omlin A, D'Addario G, Loske K, Esenwein P, Geismar J, Ruhstaller T. Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report. J Med Case Reports 2009; 3:93.
Jan 1, 2009Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report
Jan 1, 2009J Med Case Reports 2009; 3:93
Spirig Christian, Omlin Aurelius, D'Addario Giannicola, Loske Klaus-Dieter, Esenwein Philipp, Geismar Jan Henning, Ruhstaller Thomas
Review Article: Elderly patients with early non-small cell lung cancer: What are the benefits and harms of adjuvant platinum-based chemotherapy?
Früh M, Pignon J, Shepherd F. Review Article: Elderly patients with early non-small cell lung cancer: What are the benefits and harms of adjuvant platinum-based chemotherapy?. AJHO 2009; 8:76-79.
Jan 1, 2009Review Article: Elderly patients with early non-small cell lung cancer: What are the benefits and harms of adjuvant platinum-based chemotherapy?
Jan 1, 2009AJHO 2009; 8:76-79
Früh Martin, Pignon J-P, Shepherd F.A.
St. Gallen 2009 recommendations on the treatment of early breast cancer: consensus and controversy
Jörger M, Senn H, Thürlimann B. St. Gallen 2009 recommendations on the treatment of early breast cancer: consensus and controversy. magazine of european medical oncology 2009; 2:229-231.
Jan 1, 2009St. Gallen 2009 recommendations on the treatment of early breast cancer: consensus and controversy
Jan 1, 2009magazine of european medical oncology 2009; 2:229-231
Jörger Markus, Senn H J, Thürlimann Beat